Dr. Pragyan Acharya is an Associate Professor in the Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India. The major interests of her laboratory is in understand immune dysregulation in liver diseases and understanding the interaction of the immune system in tissue injury and infection. Towards this, she combines studies on clinical samples, in vitro cultures and animal models of liver disease. She is specifically studying non-alcoholic fatty liver disease (NAFLD) and acute-on-chronic liver failure (ACLF) using proteomics and cell biological approaches. Work carried out in her laboratory has led to the identification of the importance of the CD177+ neutrophil sub-population in ACLF and its association with patient outcomes.
Dr. Priyanka Banerjee earned her Ph.D. in Biochemistry (Molecular Biology) from India. She has more than 15 years of experience in Molecular Biology, Cancer biology, and is currently working working on metastatic cancer progression, cellular crosstalk in tumor microenvironment in her role as postdoctoral research associate at Texas A&M University.
Dr. Banerjee has extensive experience reviewing for multiple journals (more than 12 journals), and has published her own work in peer reviewed journals, including, Cancer Immunology Research, Redox Biology, Scientific Reports, Journal of Clinical Microbiology, Clinical Microbiology and Infection etc.
I'm currently a Senior Research Scientist in the Physiology & Health Team at AgResearch Limited, one of New Zealand's Crown Research Institutes (CRIs). I'm based at the University of Auckland's Liggins Institute, being involved in several projects investigating the importance of nutrition for health throughout life. The primary focus of these projects is intestinal health, but I'm also interested other aspects of human health, including cognition and mobility.
I graduated from The University of Auckland in May 2005 with a PhD in Biological Sciences. My thesis research focused on the importance of a mother’s diet during gestation and lactation on the risk of type-2 diabetes in her offspring. Since 2001 I've worked for AgResearch in a range of roles (including Research Associate, FRST Postdoctoral Fellow, and Research Scientist) and on a variety of topics. I was part of the Nutrigenomics New Zealand collaboration from 2004-2014, working on understanding how our diet and genome interact to influence health with a particular focus on intestinal function.
I was the Section Editor (Nutrigenomics) for the European Journal of Nutrition from 2014 to 2019.
My current research is related to autoimmune diseases, where we develop and express and characterize specific AIM biologicals as tools against diseases like Type 1 diabetes, Multiple Sclerosis, NMO, and Parkinson's disease. Apart from that, I am interested in the development of novel cancer therapies with a particular focus on Multiple Myeloma, but also investigating other solid tumors. And a last major interest is related to pregnancy and understanding more about the role of Thrombin in terms of cytokine regulation and its functional consequences for trophoblast cells.
Minjun Chen is a principal investigator working at the Division of Bioinformatics and Biostatics of the US FDA’s National Center for Toxicological Research and serve as the adjunct faculty and mentor for the bioinformatics program joint by Univ. of Arkansas at Little Rock (UALR) and Univ. of Arkansas for Medical Sciences (UAMS). Currently, he co-chairs the FDA Liver Toxicity Working Group since 2014 and is the editor of the Springer book titled “Drug-induced Liver Toxicity”. His primary research interests encompass drug-induced liver injury, drug safety, bioinformatics, and personalized medicine. He has authored or co-authored more than 80 scientific publications and book chapters.
Davide Chicco is a scientific researcher at the University of Toronto. He received his PhD. from Politecnico di Milano in 2014, and his MSc. in Computer Science from the University of Genoa, Italy in 2010. From September 2018 to January 2020 he was a researcher at the University Health Network (Toronto, Ontario, Canada). Davide Chicco's research centres on biomedical informatics and machine learning.
Degrees M.D.: University of Catania (Italy), 1974-1980. Specialist in Neurology: University of Catania, 1980-1984. Ph.D. in Medical Biochemistry and Biology: University of Bari and Catania, 1984-1986.
Professional positions: 2001- today: Full professor of Biochemistry, School of Medicine, University of Catania; 1988-2000: Associate Professor of Biochemistry, University of Catania;. 2005-2009: Director of the School of Clinical Biochemistry; 2007-2013 coordinator of the PhD School in Translational Biomedicine.
1981-2018: 134 scientific papers in international peer-reviewed journal and 25 book chapters. Citations (years 1985-2018): 4612; without self-citations: 4367 (Web of Science, ISI); h-index 40
Research training abroad: 1983: Research associate at the MRC Developmental Neurobiology Unit. London (Dir.: Prof. R. Balazs); 1989-1990: Research associate at the Neurobiochemistry Group of the Mental Retardation Center, UCLA, Los Angeles (Dir.: Prof J. De Vellis)
Research interests: Neurotransmitter and neurotrophin receptors in glial cells; structure and expression of the glial fibrillary acidic gene; molecular biology of neuronal connexins; Experimental therapy of glioma tumors; Cancer genomics; Transcriptomics.
Council of International Scientific Societies:
2000-2004: elected member of the Council of the International Society for Developmental Neuroscience. 2007-2011: elected member of the Council of the International Society for Neurochemistry.
Dr. Anissa Daliry is a biologist at the Federal College of Pernambuco (UFPE) and holds a master's degree and a PhD in cellular and molecular biology from FIOCRUZ and a postdoctoral degree from Biophysics/UFRJ. Dr. Anissa is a permanent professor of Cell and Molecular Biology program, IOC/FIOCRUZ (level 7/ CAPES) and young scientist of our state/FAPERJ (2021-2024). Her main research focus is to study molecular, physiological pathways and mechanisms involved in the development of cardiovascular and metabolic diseases such as obesity, metabolic syndrome, diabetes, hypertension, non-alcoholic fatty liver disease (NAFLD) and Chagas disease. She performs pre-clinical and clinical studies. She coordinates the postgraduate course "Cardiovascular and Metabolic Diseases: from bench to the bedside." She is a reviewer for 13 indexed international journals. Since 2020, she has collaborated in the Longitudinal Study of Brazilian Health, ELSA-BRASIL. She is also a member of the Liver Center and the Brazilian Society of Pharmacology and Experimental Therapeutics (SBFte). She develops projects in technological innovation with the development of a medical device for the quantification of hepatic steatosis. Dr. Anissa is a member of the research directory group entitled: Longitudinal Study of Adult Health - RJ/Fiocruz Research Center, coordinated by Dr. Rosane Griep/IOC and leader of the CNPq research group entitled: Study group on pathophysiology and therapy of chronic non-communicable and infectious diseases.
Assistant Professor of Clinical Medicine at the Department of Internal Medicine- Division of Gastroenterology and Hepatology at University of Missouri School of Medicine, Columbia, Missouri, USA. Faculty member of American Gastroenterology Association and American College of Gastroenterology. Faculty member and registered provider at Crohn's and Colitis Foundation. Leading faculty member of Crohn's and Colitis foundation, Mid-Missouri Chapter of Columbia, Missouri. Honored with Arnold P. Gold Foundation award for excellence in teaching. Active clinical faculty with academic education and clinical research related activities.
Dr. Lei Huang is a cancer epidemiologist, translational oncologist, digestive surgeon, surgical oncologist, and gastroenterologist. He has published about 50 papers in SCI(E)-indexed journals including Gut, Annals of Surgery, BMC Medicine, JAMA Surgery, Clinical Cancer Research, Cancer Immunology Research, International Journal of Cancer, EBioMedicine, and Gastric Cancer. His works have been cited for about 1000 times.
Dr. Huang has served on the editorial board of Frontiers in Oncology, World Journal of Gastrointestinal Oncology, PeerJ, Medicine, and Translational Cancer Research, and Frontiers in Surgery. He has been peer reviewer for about 50 SCI(E)-indexed journals including Annals of Internal Medicine, Annals of Surgery, Clinical Cancer Research, Journal of the National Comprehensive Cancer Network-JNCCN, Cancer Letters, Oncoimmunology, and Oncologist. He was selected as Best Reviewer for Annals of Internal Medicine twice in 2017 and 2019.
Dr. Huang has been invited to give oral presentations in the ASCO Annual Meeting and International Gastric Cancer Congress (IGCC), and has received Merit Awards in the ESMO Annual Meeting and Awards for Young Investigators in the IGCC.
His research interests majorly cover the epidemiological, clinical, and translational aspects of digestive cancers. He has successfully coordinated several large international investigations with participants from the US and about 20 European countries.
Dr. Dongliang Liu is a Postdoctoral Associate in the Department of Surgery at the Baylor College of Medicine. His research interests include: Cancer therapy, especially for pancreatic cancer immunotherapy; Chimeric virus-like particles (VLP) vaccine, especially for cancer vaccines; Novel antibiotics development including antimicrobial peptides; Epitomics and multi-epitope peptide vaccine development for pathogenic viruses.
Professor of Pharmacology and Toxicology, Zunyi Medical University, China. Editorial Board position on several journals including Toxicological Sciences, Environmental Health Perspective and PeerJ. Recognized by Elsevier journals and EHP as "top reviewer" in 2012 and Elsevier Journals as "top reviewer" in 2012 in the field of Pharmacology and Toxicology.